Patient

Gender

Age at start of nab-paclitaxel

Histology

Sites of metastatic disease

Prior therapies

Best response to prior therapy

1

Male

72

Pancreatic adenocarcinoma

Bone, lung

Gemcitabine

Stable

2

Female

51

Pancreatic adenocarcinoma

Liver, lung

5FU (adjuvant); gemcitabine and tremelimumab^*; OFF

Stable

3

Male

59

Pancreatic adenocarcinoma

Lung

Gemcitabine and tremelimumab^*; OFF

Stable

4

Male

74

Cholangiocarcinoma

Bone, lung

Cisplatin and gemcitabine

Progression

5

Female

67

Cholangiocarcinoma

Liver, lymph nodes

Paclitaxel, carboplatin, and etoposide; gemcitabine and 5FU; afatinib and pemetrexed^*; regorafenib drug interaction study^*

Partial response